Subject : Understanding current perceptions, newer therapies and future directions in Diabetes Management: (New- DM Survey)
Type 2 diabetes mellitus (T2DM) is a complex, metabolic and progressive disease commonly associated with diverse pathophysiology, which is characterized by relative insulin insufficiency and insulin resistance leading to excessive hepatic glucose production, and fasting and postprandial hyperglycaemia. . Pancreatic beta‐cell dysfunction is critical to disease development, and insulin resistance in the liver and peripheral target tissues also has a central role in the development of cardiometabolic changes.
The currently available glucose‐lowering agents are reviewed, and guidance for clinicians on treatment choices based on an individual patient‐centred approach is provided in guidelines. The advised treatment target is generally glycated haemoglobin (HbA1c) ≤7% (53 mmol/mol), seen as indicative of good control.
GLP‐1 RAs have been developed that are capable of resisting degradation, therefore providing longer in vivo actions with the added possibility of reduced insulin doses when used in combination while preventing weight gain and lowering the risk of hypoglycaemia compared with insulin monotherapy.
This multicentre survey is planned to understand the perceptions among healthcare practitioners in India with regard to diagnosis and management of hypertension.
We invite you to participate in this survey. On acceptance, you will need to fill the survey questionnaire form provided.We would encourage you to carefully fill all available information to the fullest in the questionnaire.
If you agree to participate in the said survey, we would request you to sign and return the enclosed reply along with your visiting card for accuracy of records.
|
}}){kind=logo}
}})